At Catalyst Clinical, we specialize in building trusted, results-driven partnerships with Sponsors and CROs. Our mission is to connect you with high-performing, independent research sites that deliver quality, reliability, and operational excellence, helping your programs advance quickly and efficiently.
We understand that every study is unique, which is why we tailor our site-matching approach to your protocol’s specific requirements. From early feasibility assessments to start-up acceleration and ongoing performance oversight, we prioritize transparency, collaboration, and ethical practices at every stage of the process.
Our clinical trial site network includes experienced sites across multiple therapeutic areas with proven track records in patient recruitment, data integrity, and compliance. By working with independent research sites, we provide Sponsors and CROs with direct access to engaged investigators and diverse patient populations, without the overhead of large SMOs or consolidated site networks.
At Catalyst Clinical, we believe in creating long-term partnerships that not only meet but exceed expectations. Our commitment to responsiveness, operational efficiency, and patient-focused care means you can trust that your studies are in capable hands.
Looking for reliable, performance-driven sites for your next study?
Contact us today to explore collaboration opportunities and learn how Catalyst Clinical can help accelerate your clinical development goals.
We limit the number of sites we work with at any given time to ensure a deep understanding of each site’s capabilities. This level of familiarity allows us to make thoughtful, well-matched recommendations to our sponsor and CRO partners.
We are happy to manage the CDA and feasibility distribution process on your behalf, or provide direct contact with our sites and PIs, so you can confirm the right fit for your study without any unnecessary hurdles.
We don’t stop at study award. We stay engaged with our sites and remain available, through 1 point of contact, to our Sponsor and CRO partners to ensure start-up and enrollment proceed smoothly. We provide guidance, maintain open communication, and offer resources to help sites overcome challenges and meet expectations.
Each site we work with undergoes a comprehensive screening process before becoming a client. This includes verifying medical licenses, reviewing FDA 483 observations, and assessing recruitment frameworks—including staffing, patient databases, community partnerships, local demographics (age, diversity), insurance coverage patterns, and geographic representation. We prioritize sites in underrepresented areas to help Sponsors and CROs reach diverse patient populations. This thorough evaluation ensures that every site meets the high standards our partners expect, while maintaining a trusted, high-quality network.
COPD, Refractory Chronic Cough, Asthma, Idiopathic Pulmonary Fibrosis, Lung Cancer Screening
Alzheimer's Disease, Migraine, Peripheral Neuropathy, Parkinson's Disease
Vaginal Atrophy, Dyspareunia, Contraceptives, Iron Deficiency Anemia, Cervical Cancer Screening, Endometrial Hyperplasia, Bacterial Vaginosis, Vulvovaginal Candidiasis, Vasomotor Symptoms in Postmenopausal Symptoms, Uterine Fibroids, Endometriosis, Heavy Menstrual Bleeding, HPV, HSV2, Tampon Applicator Device, Hysteroscopic and Laparoscopic Sterilization, FSAD
Norovirus, Covid-19, Influenza, EBV, Zika, Chikungunya, Ebola, Herpes Zoster, Meningococcal, Smallpox, RSV, Venezuelan Equine Encephalitis, Clostridium Difficile, Helicobactor Pylori
Type II Diabetes, Obesity, Low Testosterone
Hypertension, Hyperlipidemia, Dyslipidemia, Hypertriglyceridemia, Hypercholesterolemia, Coronary Artery Disease, Myocardial Infarction
Insomnia, OSA
Chronic Spontaneous Urticaria, Hydradenitis Suppurativa, Plaque Psoriasis, Vitiligo
uUTI, cUTI, Erectile Dysfunction, Hypogonadism, Overactive Bladder
Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, Gout, Psoriatic Arthritis
Eosinophilic Esophagitis, Erosive Esophagitis, GERD, NERD, IBD, Diabetic Gastroparesis, NASH, NAFLD, Gastric Ulcers, Opioid Induced Bowel Dysfunction, Ulcerative Colitis, Constipation
Catalyst Clinical Consulting